世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

放射線治療市場：タイプ別（製品、サービス）、技術別（MRIリニアック、定位放射線治療、粒子線治療、コバルト60線治療）、術式別（IMRT、IGRT、3D-CRT、LDR、HDR）、用途別（前立腺、乳房、肺）、エンドユーザー別（病院）、地域別 - 2028年までの世界予測


Radiotherapy Market by Type (Product, Service), Technology (MRI LINAC, Stereotactic, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT, 3D-CRT, LDR, HDR), Application (Prostate, Breast, Lung), End User (Hospital) & Region - Global Forecast to 2028

世界の放射線治療市場は、2023年の69億米ドルから2028年には88億米ドルに達し、予測期間中のCAGRは5.0％で成長すると予測されている。世界的ながん罹患率の上昇、放射線治療技術の進歩、世界的ながんセンターでの... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年11月10日 US$4,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		277 264 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

世界の放射線治療市場は、2023年の69億米ドルから2028年には88億米ドルに達し、予測期間中のCAGRは5.0％で成長すると予測されている。世界的ながん罹患率の上昇、放射線治療技術の進歩、世界的ながんセンターでの粒子線治療の採用拡大が、予測期間中の放射線治療市場の成長を後押しするとみられる。

"世界の放射線治療市場のソフトウェア＆サービス分野が予測期間中に最も高いCAGRで成長する "
放射線治療市場はタイプに基づき、製品とソフトウェア＆サービスに区分される。ソフトウェア＆サービス分野は、主に北米や欧州などの確立された市場で高い成長率を記録すると予想されている。放射線治療の進歩や、より正確で個別化されたがん治療計画への需要の高まりが、革新的な放射線治療ソフトウェア＆サービスの開発につながっている。

"技術別では、外部ビーム放射線治療分野が2022年の世界放射線治療システム市場で最大の市場シェアを占めている。"

技術に基づき、放射線治療市場は外部ビーム放射線治療と内部ビーム放射線治療に区分される。外部ビーム放射線治療（EBRT）セグメントは、外部ビーム放射線治療技術が広く採用されていること、および先進的な外部ビーム放射線治療技術の開発と商業化のために市場プレーヤーが研究開発に継続的に投資していることから、2022年に放射線治療の最大シェアを占めた。

"前立腺がんは、外部ビーム放射線治療の用途別で、2022年に最大の市場シェアを占めた。"

放射線治療市場は、用途別に外部照射放射線治療用途と内部照射放射線治療/ブラキセラピー用途の2つに大別される。
外部ビーム放射線治療の用途は、さらに乳がん、前立腺がん、頭頸部がん、肺がん、大腸がん、その他のがんに分類される。
内部ビーム放射線治療/brachytherapy用途は、さらに前立腺がん、婦人科がん、乳がん、子宮頸がん、陰茎がん、その他のがん（肺がん、頭頸部がん）に分けられる。
前立腺がんは、世界的な前立腺がん罹患率の増加、前立腺がんに対する外部ビーム放射線治療が提供する利点、前立腺がん治療のための放射線治療分野における研究活動の増加により、2022年に最大の市場シェアを占めた。

地域別では北米が放射線治療市場で最大のシェアを占めている。
世界の放射線治療市場は、北米、欧州、アジア太平洋、中南米、中東・アフリカの5つの主要地域に区分される。北米は放射線治療製品・サービスの最大地域市場であるのに対し、アジア太平洋市場は予測期間中に最も高いCAGRで成長すると推定されている。北米の最大シェアは、先進的な放射線治療技術の急速な導入、放射線治療ソフトウェアメーカーとエンドユーザー間の協力関係の増加、北米各国の医療施設とサービスの多様なネットワークの存在、同地域のがん治療を支える有利な償還モデルに起因している。

本レポートで参照した主な参加企業の内訳は以下の通りである：
- 企業タイプ別Tier1〜48％、Tier2〜36％、Tier3〜16
- 役職別Cレベル-10%、ディレクターレベル-14%、その他-76
- 地域別北米-40%、欧州-32%、アジア太平洋地域-20%、ラテンアメリカ-5%、MEA-3
放射線治療市場における主なプレーヤーは、シーメンス・ヘルスケア社（ドイツ）、エレクタ社（スウェーデン）、アキュレイ社（米国）、IBA社（ベルギー）、ビューレイ・テクノロジーズ社（米国）、C-RAD社（スウェーデン）、IBAワールドワイド社（ベルギー）、日立製作所（日本（米国））、Mev.(日本（米国）、Mevion Medical Systems社（米国）、Optivus Proton Therapy社（米国）、Panacea Medical Technologies Pvt.(インド）などがある。

調査範囲
本レポートでは、放射線治療市場を製品、技術、用途、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダー向けに競争状況の詳細を提供しています。さらに、個々の成長動向に関してミクロ市場を分析し、4つの主要地域（およびこれらの地域のそれぞれの国）に関して市場セグメントの収益を予測しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握することができ、ひいては、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入する企業は、以下の戦略の1つまたは組み合わせを使用して、市場での存在感を強化することができます。

本レポートは、以下のポイントに関する洞察を提供する：
- 放射線治療市場の成長に影響を与える主な促進要因（技術の進歩、がん有病率の上昇、粒子線治療の利用拡大）、阻害要因（適切な医療の不足、自動放射線治療システムの高コスト、熟練放射線科医の不足）、機会（発展途上国における医療費の上昇）、課題（放射線被ばくのリスク）の分析
 市場の浸透：放射線治療市場のトップ企業が提供する製品ポートフォリオに関する包括的情報
 製品開発/イノベーション：放射線治療市場における今後の動向、研究開発活動、製品発売に関する詳細な洞察
 市場開発：有利な新興地域に関する包括的情報
 市場の多様化：放射線治療市場における新製品、成長地域、最新動向に関する網羅的情報
 競合評価：市場セグメント、成長戦略、収益分析、主要市場プレイヤーの製品に関する詳細な評価。

ページTOPに戻る


目次

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 36
1.3 STUDY SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 REGIONS COVERED 38
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 38
1.4 KEY STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 39
1.6 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 1 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.2 PRIMARY RESEARCH 42
2.1.2.1 Key data from primary sources 42
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 43
FIGURE 3 GLOBAL RADIOTHERAPY MARKET: BREAKDOWN OF PRIMARIES 43
2.2 MARKET SIZE ESTIMATION METHODOLOGY 43
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 44
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 44
2.2.2 USAGE-BASED MARKET ESTIMATION 45
FIGURE 5 MARKET SIZE ESTIMATION: GLOBAL RADIOTHERAPY MARKET 45
2.2.3 PRIMARY RESEARCH VALIDATION 46
2.3 DATA TRIANGULATION 47
FIGURE 6 DATA TRIANGULATION METHODOLOGY 47
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 48
2.4.1 RESEARCH ASSUMPTIONS 48
2.4.2 RESEARCH LIMITATIONS 48
2.5 RECESSION IMPACT ANALYSIS 48
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 48
 
3 EXECUTIVE SUMMARY 50
FIGURE 7 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 50
FIGURE 8 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 51
FIGURE 9 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 51
FIGURE 10 RADIOTHERAPY MARKET SHARE, BY END USER, 2023 VS. 2028 52
FIGURE 11 RADIOTHERAPY MARKET: GEOGRAPHICAL SNAPSHOT 53
4 PREMIUM INSIGHTS 54
4.1 RADIOTHERAPY MARKET OVERVIEW 54
FIGURE 12 RISING CANCER PREVALENCE WORLDWIDE TO DRIVE GROWTH 54
4.2 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 55
4.3 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TECHNOLOGY AND REGION (2022) 55
FIGURE 13 LINACS HELD LARGEST SHARE IN 2O22 55
4.4 RADIOTHERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 14 CHINA TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Advancements in radiotherapy treatment technology 58
5.2.1.2 Growing patient population 59
FIGURE 16 PROJECTED INCREASE IN CANCER CASES, 2020–2040 59
5.2.1.3 Increasing initiatives to promote radiotherapy awareness 59
5.2.1.4 Growing use of particle therapy for cancer treatment 60
5.2.2 RESTRAINTS 60
5.2.2.1 Lack of adequate healthcare infrastructure 60
5.2.2.2 High capital cost of radiotherapy 61
5.2.2.3 Complexity of radiotherapy 61
5.2.3 OPPORTUNITIES 62
5.2.3.1 Emerging economies 62
5.2.3.2 Favorable changes in US radiotherapy payment model 62
5.2.3.3 Government and private investments to meet rising demand for cancer treatment 63
5.2.4 CHALLENGES 63
5.2.4.1 Dearth of skilled personnel 63
5.2.4.2 Difficulties in visualizing tumors during radiotherapy 64
5.2.4.3 Risk of radiation exposure 64
5.3 PORTER’S FIVE FORCES ANALYSIS 65
TABLE 2 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 65
5.3.1 THREAT OF NEW ENTRANTS 65
5.3.2 THREAT OF SUBSTITUTES 65
5.3.3 BARGAINING POWER OF SUPPLIERS 65
5.3.4 BARGAINING POWER OF BUYERS 65
5.3.5 DEGREE OF COMPETITION 66
5.4 REGULATORY LANDSCAPE 66
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.4.1 NORTH AMERICA 67
5.4.1.1 US 67
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
5.4.2 CANADA 68
TABLE 7 CLASS II PRESCRIBED EQUIPMENT CERTIFICATES 68
5.4.3 EUROPE 69
5.4.4 ASIA PACIFIC 70
5.4.4.1 China 70
5.4.4.2 Japan 70
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 71
5.4.5 INDIA 71
5.5 REIMBURSEMENT SCENARIO 71
TABLE 9 CPT CODES FOR MAJOR RADIOTHERAPY TREATMENT MODALITIES 72
TABLE 10 REIMBURSEMENT FOR RADIOTHERAPY PROCEDURES PER COURSE, 2021 VS 2022 72
TABLE 11 OPPS TECHNICAL PER PROCEDURE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022 73
TABLE 12 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022 73
5.6 ECOSYSTEM/MARKET MAP 74
5.7 VALUE CHAIN ANALYSIS 74
5.7.1 RESEARCH & DEVELOPMENT 74
5.7.2 PROCUREMENT AND PRODUCT DEVELOPMENT 74
5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 74
FIGURE 17 VALUE CHAIN ANALYSIS 75
5.8 SUPPLY CHAIN ANALYSIS 75
5.8.1 PROMINENT COMPANIES 75
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES 75
5.8.3 END USERS 76
FIGURE 18 SUPPLY CHAIN ANALYSIS 76
5.9 TRADE DATA 76
TABLE 13 IMPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION) 76
TABLE 14 EXPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION) 77
5.10 PRICING ANALYSIS 77
FIGURE 19 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS 77
TABLE 15 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS (USD) 78
TABLE 16 AVERAGE SELLING PRICE TRENDS 78
5.11 KEY CONFERENCES & EVENTS IN 2023–2025 78
TABLE 17 RADIOTHERAPY MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS 78
5.12 TECHNOLOGY ANALYSIS 80
5.13 PATENT ANALYSIS 81
FIGURE 20 TOP PATENT APPLICANTS FOR PROTON BEAM THERAPY, JANUARY 2012–OCTOBER 2023 81
FIGURE 21 TOP PATENT APPLICANTS FOR MEDICAL LINEAR ACCELERATORS, JANUARY 2012–OCTOBER 2023 82
5.14 CASE STUDY ANALYSIS 82
TABLE 18 CASE STUDY: ENHANCING PATIENT SAFETY—SBRT’S ROLE IN MINIMIZING RADIATION RISK IN AN ELDERLY PATIENT (90-YEAR-OLD FEMALE WITH A MEDICALLY INOPERABLE EARLY-STAGE NSCLC) 82
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 83
FIGURE 22 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 83
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 83
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS 83
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY DEVICES 84
5.16.2 BUYING CRITERIA 84
FIGURE 24 KEY BUYING CRITERIA FOR RADIOTHERAPY 84
TABLE 20 KEY BUYING CRITERIA FOR RADIOTHERAPY 84
6 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE 85
6.1 INTRODUCTION 86
TABLE 21 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2022–2028 (USD MILLION) 86
6.2 PRODUCTS 86
6.2.1 CONTINUOUS DEVELOPMENT OF ADVANCED TECHNOLOGIES TO BOOST MARKET 86
TABLE 22 RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2022–2028 (USD MILLION) 87
 
6.3 SOFTWARE & SERVICES 87
6.3.1 INCREASING DEMAND FOR PRECISE AND EFFECTIVE CANCER TREATMENT TO SUPPORT MARKET GROWTH 87
TABLE 23 RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2022–2028 (USD MILLION) 88
7 RADIOTHERAPY MARKET, BY TECHNOLOGY 89
7.1 INTRODUCTION 90
TABLE 24 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 90
7.2 EXTERNAL BEAM RADIOTHERAPY 90
TABLE 25 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 90
TABLE 26 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 91
7.3 LINACS 91
TABLE 27 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 91
TABLE 28 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
7.3.1 CONVENTIONAL LINACS 92
7.3.1.1 Long treatment duration to limit adoption 92
TABLE 29 CONVENTIONAL LINACS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
7.3.2 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS 93
TABLE 30 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 31 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
7.3.2.1 CyberKnife 94
7.3.2.1.1 Precise radiation delivery with robotic correction capabilities to drive market 94
TABLE 32 CYBERKNIFE MARKET, BY REGION, 2021–2028 (USD MILLION) 94
7.3.2.2 Gamma Knife 95
7.3.2.2.1 Ongoing product development and launches to support growth 95
TABLE 33 GAMMA KNIFE MARKET, BY REGION, 2021–2028 (USD MILLION) 95
7.3.2.3 TomoTherapy 96
7.3.2.3.1 High installation and maintenance costs to limit adoption 96
TABLE 34 TOMOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 96
7.3.3 MRI LINACS 96
7.3.3.1 Real-time imaging advantage to propel growth 96
TABLE 35 MRI LINACS MARKET, BY REGION, 2022–2028 (USD MILLION) 97
7.4 PARTICLE THERAPY 97
TABLE 36 PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2021–2028 (USD MILLION) 97
TABLE 37 PARTICLE THERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 98
7.4.1 CYCLOTRONS 98
7.4.1.1 Enhanced outcomes and other advantages to boost adoption 98
TABLE 38 CYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION) 99
7.4.2 SYNCHROTRONS 99
7.4.2.1 Increasing investments in synchrotron facilities to drive market 99
TABLE 39 SYNCHROTRONS MARKET, BY REGION, 2021–2028 (USD MILLION) 100
7.4.3 SYNCHROCYCLOTRONS 100
7.4.3.1 High space requirements limit widespread adoption 100
TABLE 40 SYNCHROCYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION) 100
7.5 CONVENTIONAL COBALT-60 TELETHERAPY 101
7.5.1 COMPLEX DOSE DELIVERY PLANNING AND RADIATION EXPOSURE TO LIMIT MARKET ADOPTION 101
TABLE 41 CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 101
7.6 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY 102
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 102
7.7 SEEDS 103
7.7.1 ADVERSE SIDE-EFFECTS ASSOCIATED WITH SEEDS TO LIMIT ADOPTION 103
TABLE 44 SEEDS MARKET, BY REGION, 2021–2028 (USD MILLION) 103
7.8 AFTERLOADERS 103
7.8.1 PROPER POSITIONING AND BETTER CONTROL OF ISOTOPES IN MODERN AFTERLOADERS TO DRIVE DEMAND 103
TABLE 45 AFTERLOADERS MARKET, BY REGION, 2021–2028 (USD MILLION) 104
7.9 IORT SYSTEMS 104
7.9.1 RISING ADOPTION OF ELECTRONIC BRACHYTHERAPY PROCEDURES TO SUPPORT GROWTH 104
TABLE 46 IORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
7.10 APPLICATORS 105
7.10.1 HIGH RISK OF RADIATION EXPOSURE IN MANUAL APPLICATORS TO LIMIT GROWTH 105
TABLE 47 APPLICATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 106
7.11 SYSTEMIC RADIOTHERAPY 106
7.11.1 HIGH RISK OF RADIATION EXPOSURE TO LIMIT ADOPTION 106
7.11.2 IOBENGUANE (I-131) 106
7.11.3 SAMARIUM-153 107
7.11.4 RHENIUM-186 107
7.11.5 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS 107
8 RADIOTHERAPY MARKET, BY APPLICATION 108
8.1 INTRODUCTION 109
TABLE 48 RADIOTHERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109
8.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS 109
TABLE 49 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 109
TABLE 50 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION) 110
8.2.1 PROSTATE CANCER 110
8.2.1.1 High incidence rate and efficiency of EBRT in prostate cancer treatment to support growth 110
TABLE 51 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION) 111
8.2.2 BREAST CANCER 111
8.2.2.1 Therapeutic benefits of EBRT to drive market 111
TABLE 52 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION) 112
8.2.3 LUNG CANCER 112
8.2.3.1 High prevalence of lung cancer and efficiency of EBRT to drive market 112
TABLE 53 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION) 113
8.2.4 HEAD & NECK CANCER 113
8.2.4.1 Noninvasive treatment of head & neck cancers to drive market 113
TABLE 54 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2021–2028 (USD MILLION) 113
8.2.5 COLORECTAL CANCER 114
8.2.5.1 High incidence of colorectal cancer to support market growth 114
TABLE 55 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2021–2028 (USD MILLION) 114
8.2.6 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS 114
TABLE 56 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION) 115
8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS 115
TABLE 57 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 115
TABLE 58 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 116
8.3.1 PROSTATE CANCER 116
8.3.1.1 Precision of brachytherapy to drive market 116
TABLE 59 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2022–2028 (USD MILLION) 117
8.3.2 GYNECOLOGICAL CANCER 117
8.3.2.1 Availability of alternatives to hinder adoption of brachytherapy 117
TABLE 60 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2021–2028 (USD MILLION) 118
8.3.3 BREAST CANCER 118
8.3.3.1 Wide usage as replacement for traditional EBRT to drive market 118
TABLE 61 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION) 119
8.3.4 CERVICAL CANCER 119
8.3.4.1 Effectiveness of combined brachytherapy-chemotherapy procedure to support adoption 119
TABLE 62 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2021–2028 (USD MILLION) 120
8.3.5 PENILE CANCER 120
8.3.5.1 Rising awareness and effectiveness of brachytherapy to drive market 120
TABLE 63 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2021–2028 (USD MILLION) 121
8.3.6 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS 121
TABLE 64 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
9 RADIOTHERAPY MARKET, BY PROCEDURE 123
9.1 INTRODUCTION 124
TABLE 65 RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2028 (USD MILLION) 124
9.2 EXTERNAL BEAM RADIOTHERAPY 124
TABLE 66 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 67 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION) 125
9.2.1 IMRT 125
9.2.1.1 Advantages over 2D and 3D-CRT to boost adoption 125
TABLE 68 IMRT MARKET, BY REGION, 2021–2028 (USD MILLION) 126
9.2.2 IGRT 126
9.2.2.1 Growing demand in treating deep-seated tumors to drive market 126
TABLE 69 IGRT MARKET, BY REGION, 2021–2028 (USD MILLION) 127
9.2.3 3D CONFORMAL RADIOTHERAPY 127
9.2.3.1 High precision and minimized damage to nearby tissues to boost adoption 127
TABLE 70 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 128
9.2.4 SRT 128
9.2.4.1 Minimally invasive procedure to drive end-user preference 128
TABLE 71 SRT MARKET, BY REGION, 2021–2028 (USD MILLION) 129
9.2.5 PARTICLE THERAPY 129
9.2.5.1 High usage as primary mode of cancer treatment to sustain market growth 129
TABLE 72 PARTICLE THERAPY MARKET, BY REGION, 2022–2028 (USD MILLION) 130
9.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY 130
TABLE 73 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 74 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION) 131
9.3.1 LDR BRACHYTHERAPY 131
9.3.1.1 Low risk of radiation exposure to surrounding tissues to drive adoption 131
TABLE 75 LDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 132
9.3.2 HDR BRACHYTHERAPY 132
9.3.2.1 Possibility of tissue injury to affect adoption 132
TABLE 76 HDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 132
9.3.3 PDR BRACHYTHERAPY 133
9.3.3.1 Combination of advantages to boost growth 133
TABLE 77 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 133
9.4 SYSTEMIC RADIOTHERAPY 133
9.4.1 HIGH COST OF RADIOPHARMACEUTICALS AND RISK OF RADIATION EXPOSURE TO LIMIT USAGE 133
9.4.2 INTRAVENOUS RADIOTHERAPY 134
9.4.3 ORAL RADIOTHERAPY 134
9.4.4 INSTILLATION RADIOTHERAPY 134
10 RADIOTHERAPY MARKET, BY END USER 135
10.1 INTRODUCTION 136
TABLE 78 RADIOTHERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 136
10.2 HOSPITALS 136
10.2.1 HOSPITALS TO DOMINATE END-USER MARKET 136
TABLE 79 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 137
10.3 INDEPENDENT RADIOTHERAPY CENTERS 137
10.3.1 LOWER OPERATING COSTS AND CONVENIENCE TO SUPPORT MARKET GROWTH 137
TABLE 80 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021–2028 (USD MILLION) 137
11 RADIOTHERAPY MARKET, BY REGION 138
11.1 INTRODUCTION 139
TABLE 81 RADIOTHERAPY MARKET, BY REGION, 2022–2028 (USD MILLION) 139
11.2 NORTH AMERICA 139
11.2.1 NORTH AMERICA: RECESSION IMPACT 139
FIGURE 25 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT 140
TABLE 82 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 141
TABLE 83 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 141
TABLE 84 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 141
TABLE 85 NORTH AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 142
TABLE 86 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 142
TABLE 87 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 142
TABLE 88 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 143
TABLE 89 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 143
TABLE 90 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 144
TABLE 91 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 144
11.2.2 US 144
11.2.2.1 Changes in reimbursement scenario to drive market growth 144
TABLE 92 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 145
TABLE 93 US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 146
TABLE 94 US: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 146
TABLE 95 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 146
11.2.3 CANADA 147
11.2.3.1 Growing prevalence of cancer to drive demand for radiotherapy 147
TABLE 96 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 147
TABLE 97 CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 148
TABLE 98 CANADA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 148
TABLE 99 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 148
11.3 EUROPE 149
11.3.1 EUROPE: RECESSION IMPACT 149
TABLE 100 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 150
TABLE 101 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 150
TABLE 102 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 150
TABLE 103 EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 151
TABLE 104 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 151
TABLE 105 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 151
TABLE 106 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 152
TABLE 107 EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 152
TABLE 108 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 153
TABLE 109 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 153
11.3.2 GERMANY 153
11.3.2.1 Availability of novel radiotherapy products to drive market 153
TABLE 110 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 154
TABLE 111 GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 155
TABLE 112 GERMANY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 155
TABLE 113 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 155
11.3.3 FRANCE 156
11.3.3.1 High purchasing & maintenance costs of advanced radiotherapy systems to limit market growth 156
TABLE 114 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 156
TABLE 115 FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 156
TABLE 116 FRANCE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 157
TABLE 117 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 157
11.3.4 UK 157
11.3.4.1 High healthcare expenditure to drive market 157
TABLE 118 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 158
TABLE 119 UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 158
TABLE 120 UK: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 159
TABLE 121 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 159
11.3.5 SPAIN 159
11.3.5.1 Growing research activities on cancer care drive market 159
TABLE 122 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 160
TABLE 123 SPAIN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 161
TABLE 124 SPAIN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 161
TABLE 125 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 161
11.3.6 ITALY 162
11.3.6.1 High number of oncology-specific clinical trials & studies to support market growth 162
TABLE 126 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 162
TABLE 127 ITALY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 163
TABLE 128 ITALY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 163
TABLE 129 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 163
11.3.7 REST OF EUROPE 164
TABLE 130 REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 164
TABLE 131 REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 164
TABLE 132 REST OF EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 165
TABLE 133 REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 165
11.4 ASIA PACIFIC 165
11.4.1 ASIA PACIFIC: RECESSION IMPACT 166
FIGURE 26 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT 167
TABLE 134 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 168
TABLE 135 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 168
TABLE 136 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 169
TABLE 137 ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 169
TABLE 138 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 170
TABLE 139 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 170
TABLE 140 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 171
TABLE 141 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 171
TABLE 142 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 172
TABLE 143 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 172
11.4.2 JAPAN 172
11.4.2.1 Rising geriatric population and cancer incidence to drive market 172
TABLE 144 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 173
TABLE 145 JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 173
TABLE 146 JAPAN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 174
TABLE 147 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 174
11.4.3 CHINA 174
11.4.3.1 Growing partnerships among market players to support growth 174
TABLE 148 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 175
TABLE 149 CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 175
TABLE 150 CHINA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 176
TABLE 151 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 176
11.4.4 INDIA 176
11.4.4.1 High need for radiotherapy systems to provide opportunities 176
TABLE 152 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 177
TABLE 153 INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 177
TABLE 154 INDIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 178
TABLE 155 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 178
11.4.5 SOUTH KOREA 178
11.4.5.1 Increasing incidence of cancer to support market 178
TABLE 156 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 179
TABLE 157 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 179
TABLE 158 SOUTH KOREA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 180
TABLE 159 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 180
11.4.6 AUSTRALIA 180
11.4.6.1 Availability of funding for cancer care & research to drive growth 180
TABLE 160 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 181
TABLE 161 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 181
TABLE 162 AUSTRALIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 182
TABLE 163 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 182
11.4.7 REST OF ASIA PACIFIC 182
TABLE 164 REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 183
TABLE 165 REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 183
TABLE 166 REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 184
TABLE 167 REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 184
11.5 LATIN AMERICA 184
11.5.1 LATIN AMERICA: RECESSION IMPACT 185
TABLE 168 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 185
TABLE 169 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 185
TABLE 170 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 186
TABLE 171 LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 186
TABLE 172 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 186
TABLE 173 LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 187
TABLE 174 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2023–2028 (USD MILLION) 187
TABLE 175 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 188
TABLE 176 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 188
TABLE 177 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 189
11.5.2 BRAZIL 189
11.5.2.1 Restricted affordability & access to radiotherapy to challenge market growth 189
TABLE 178 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 189
TABLE 179 BRAZIL: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 190
TABLE 180 BRAZIL: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 190
TABLE 181 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 190
11.5.3 MEXICO 191
11.5.3.1 Rising target population to boost market growth 191
TABLE 182 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 191
TABLE 183 MEXICO: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 192
TABLE 184 MEXICO: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 192
TABLE 185 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 192
11.5.4 REST OF LATIN AMERICA 193
TABLE 186 REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 193
TABLE 187 REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 193
TABLE 188 REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 194
TABLE 189 REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 194
11.6 MIDDLE EAST & AFRICA 194
11.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET 194
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 195
TABLE 190 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 195
TABLE 191 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 196
TABLE 192 MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 196
TABLE 193 MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 196
TABLE 194 MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 197
TABLE 195 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 197
TABLE 196 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 198
TABLE 197 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 198
TABLE 198 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 199
12 COMPETITIVE LANDSCAPE 200
12.1 OVERVIEW 200
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 200
FIGURE 27 OVERVIEW OF STRATEGIES ADOPTED BY KEY RADIOTHERAPY PLAYERS (2020 TO 2023) 201
12.3 REVENUE ANALYSIS 202
FIGURE 28 REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019–2022 202
12.4 MARKET SHARE ANALYSIS 202
FIGURE 29 RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022 202
12.5 COMPANY EVALUATION MATRIX 203
12.5.1 STARS 203
12.5.2 EMERGING LEADERS 203
12.5.3 PERVASIVE PLAYERS 203
12.5.4 PARTICIPANTS 203
FIGURE 30 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022 204
12.5.5 COMPANY FOOTPRINT 205
TABLE 199 PRODUCT FOOTPRINT (18 COMPANIES) 205
TABLE 200 REGIONAL FOOTPRINT (18 COMPANIES) 206
TABLE 201 COMPANY FOOTPRINT (18 COMPANIES) 207
12.6 START-UP/SME EVALUATION MATRIX 207
12.6.1 PROGRESSIVE COMPANIES 207
12.6.2 RESPONSIVE COMPANIES 208
12.6.3 DYNAMIC COMPANIES 208
12.6.4 STARTING BLOCKS 208
FIGURE 31 RADIOTHERAPY MARKET: START-UP/SME EVALUATION MATRIX, 2022 208
12.6.5 COMPETITIVE BENCHMARKING 209
TABLE 202 RADIOTHERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES 209
12.7 COMPETITIVE SCENARIO AND TRENDS 210
12.7.1 PRODUCT LAUNCHES & APPROVALS 210
12.7.2 DEALS 210
12.7.3 OTHER DEVELOPMENTS 211

　

ページTOPに戻る


　

Summary

The global radiotherapy market is projected to reach USD 8.8 billion by 2028 from USD 6.9 billion in 2023, growing at a CAGR of 5.0% during the forecast period. The rising incidence of cancer worldwide, advancements in radiotherapy treatment technologies, and growing adoption of particle therapy among cancer centers globally are likely to support the growth of radiotherapy market during the forecast period.

“ Software & Services segment of global radiotherapy market to grow with the highest CAGR in the forecast period.”
Based on type, the radiotherapy market is segmented into products and software & services. The software & service segment is expected to register a higher growth rate majorly in well-established market such as North America and Europe. The ongoing advancements in radiotherapy and increasing demand for more precise, and personalized cancer care treatment plan are leading towards the development of innovative radiotherapy softwares & services.

“ External Beam Radiotherapy segment, by technology , accounted for the largest market share of global radiotherapy system market in 2022.”

Based on technology, the radiotherapy market has been segmented into external beam radiotherapy and internal beam radiotherapy. The external beam radiotherapy (EBRT) segment accounted for the largest share of radiotherapy in 2022, owing to widespread adoption external beam radiotherapy technology and continuous investment in R&D by market players for development and commercializing advanced external beam radiotherapy technologies.

“ Prostate cancer, by external beam radiotherapy application , accounted for the largest market share of in 2022.”

Based on application, the radiotherapy market is classified into two major segments—external beam radiotherapy and internal beam radiotherapy/brachytherapy applications.
The external beam radiotherapy applications segment is further segmeneted into breast, prostate cancer, head and neck cancer, lung cancer, colorectla cancer and other cancer
The internal beam radiotherapy/brachytherapy applications segment is further divided into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers (lung cancer and head and neck cancers).
Prostate cancer accounted for the largest market share in 2022 owing to the increasing incidence of prostate cancer globally, advantages offered by external beam radiotherapy treatment for prostate cancer, and increase in research activities in the field of radiation therapy for prostate cancer treatment

North America accounted for the largest share of the radiotherapy market by region.
The global radiotherapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for radiotherapy products and services , whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The largest share of North America can be attributed to the rapid adoption of advanced radiotherapy technologies, increases collaboration among radiotherapy software manufacturers and end users, presence of diverse network of healthcare facilities and services across countries of North America , and favorable reimbursement models supporting cancer care in the region

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, MEA- 3%
The prominent players in the radiotherapy market are Siemens Healthcare GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), C-RAD (Sweden), IBA Worldwide (Belgium), Hitachi Ltd. (Japan (US), Mevion Medical Systems (US), Optivus Proton Therapy, Inc. (US) and Panacea Medical Technologies Pvt. Ltd. (India), among others.

Research Coverage
This report studies the radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:
• Analysis of key drivers (technological advancements, rising prevalence of cancer, growing use of particle therapy), restraints (lack of adequate healthcare, high cost of automated radiation therapy systems, dearth of skilled radiologist), opportunities (rising healthcare expenditure across developing countries), and challenges (risk of radiation exposure) influencing the growth of radiotherapy market
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the radiotherapy market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the radiotherapy market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the radiotherapy market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 36
1.3 STUDY SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 REGIONS COVERED 38
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 38
1.4 KEY STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 39
1.6 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 1 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.2 PRIMARY RESEARCH 42
2.1.2.1 Key data from primary sources 42
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 43
FIGURE 3 GLOBAL RADIOTHERAPY MARKET: BREAKDOWN OF PRIMARIES 43
2.2 MARKET SIZE ESTIMATION METHODOLOGY 43
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 44
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 44
2.2.2 USAGE-BASED MARKET ESTIMATION 45
FIGURE 5 MARKET SIZE ESTIMATION: GLOBAL RADIOTHERAPY MARKET 45
2.2.3 PRIMARY RESEARCH VALIDATION 46
2.3 DATA TRIANGULATION 47
FIGURE 6 DATA TRIANGULATION METHODOLOGY 47
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 48
2.4.1 RESEARCH ASSUMPTIONS 48
2.4.2 RESEARCH LIMITATIONS 48
2.5 RECESSION IMPACT ANALYSIS 48
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 48
 
3 EXECUTIVE SUMMARY 50
FIGURE 7 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 50
FIGURE 8 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 51
FIGURE 9 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 51
FIGURE 10 RADIOTHERAPY MARKET SHARE, BY END USER, 2023 VS. 2028 52
FIGURE 11 RADIOTHERAPY MARKET: GEOGRAPHICAL SNAPSHOT 53
4 PREMIUM INSIGHTS 54
4.1 RADIOTHERAPY MARKET OVERVIEW 54
FIGURE 12 RISING CANCER PREVALENCE WORLDWIDE TO DRIVE GROWTH 54
4.2 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 55
4.3 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TECHNOLOGY AND REGION (2022) 55
FIGURE 13 LINACS HELD LARGEST SHARE IN 2O22 55
4.4 RADIOTHERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 14 CHINA TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Advancements in radiotherapy treatment technology 58
5.2.1.2 Growing patient population 59
FIGURE 16 PROJECTED INCREASE IN CANCER CASES, 2020–2040 59
5.2.1.3 Increasing initiatives to promote radiotherapy awareness 59
5.2.1.4 Growing use of particle therapy for cancer treatment 60
5.2.2 RESTRAINTS 60
5.2.2.1 Lack of adequate healthcare infrastructure 60
5.2.2.2 High capital cost of radiotherapy 61
5.2.2.3 Complexity of radiotherapy 61
5.2.3 OPPORTUNITIES 62
5.2.3.1 Emerging economies 62
5.2.3.2 Favorable changes in US radiotherapy payment model 62
5.2.3.3 Government and private investments to meet rising demand for cancer treatment 63
5.2.4 CHALLENGES 63
5.2.4.1 Dearth of skilled personnel 63
5.2.4.2 Difficulties in visualizing tumors during radiotherapy 64
5.2.4.3 Risk of radiation exposure 64
5.3 PORTER’S FIVE FORCES ANALYSIS 65
TABLE 2 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 65
5.3.1 THREAT OF NEW ENTRANTS 65
5.3.2 THREAT OF SUBSTITUTES 65
5.3.3 BARGAINING POWER OF SUPPLIERS 65
5.3.4 BARGAINING POWER OF BUYERS 65
5.3.5 DEGREE OF COMPETITION 66
5.4 REGULATORY LANDSCAPE 66
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.4.1 NORTH AMERICA 67
5.4.1.1 US 67
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
5.4.2 CANADA 68
TABLE 7 CLASS II PRESCRIBED EQUIPMENT CERTIFICATES 68
5.4.3 EUROPE 69
5.4.4 ASIA PACIFIC 70
5.4.4.1 China 70
5.4.4.2 Japan 70
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 71
5.4.5 INDIA 71
5.5 REIMBURSEMENT SCENARIO 71
TABLE 9 CPT CODES FOR MAJOR RADIOTHERAPY TREATMENT MODALITIES 72
TABLE 10 REIMBURSEMENT FOR RADIOTHERAPY PROCEDURES PER COURSE, 2021 VS 2022 72
TABLE 11 OPPS TECHNICAL PER PROCEDURE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022 73
TABLE 12 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022 73
5.6 ECOSYSTEM/MARKET MAP 74
5.7 VALUE CHAIN ANALYSIS 74
5.7.1 RESEARCH & DEVELOPMENT 74
5.7.2 PROCUREMENT AND PRODUCT DEVELOPMENT 74
5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 74
FIGURE 17 VALUE CHAIN ANALYSIS 75
5.8 SUPPLY CHAIN ANALYSIS 75
5.8.1 PROMINENT COMPANIES 75
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES 75
5.8.3 END USERS 76
FIGURE 18 SUPPLY CHAIN ANALYSIS 76
5.9 TRADE DATA 76
TABLE 13 IMPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION) 76
TABLE 14 EXPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION) 77
5.10 PRICING ANALYSIS 77
FIGURE 19 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS 77
TABLE 15 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS (USD) 78
TABLE 16 AVERAGE SELLING PRICE TRENDS 78
5.11 KEY CONFERENCES & EVENTS IN 2023–2025 78
TABLE 17 RADIOTHERAPY MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS 78
5.12 TECHNOLOGY ANALYSIS 80
5.13 PATENT ANALYSIS 81
FIGURE 20 TOP PATENT APPLICANTS FOR PROTON BEAM THERAPY, JANUARY 2012–OCTOBER 2023 81
FIGURE 21 TOP PATENT APPLICANTS FOR MEDICAL LINEAR ACCELERATORS, JANUARY 2012–OCTOBER 2023 82
5.14 CASE STUDY ANALYSIS 82
TABLE 18 CASE STUDY: ENHANCING PATIENT SAFETY—SBRT’S ROLE IN MINIMIZING RADIATION RISK IN AN ELDERLY PATIENT (90-YEAR-OLD FEMALE WITH A MEDICALLY INOPERABLE EARLY-STAGE NSCLC) 82
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 83
FIGURE 22 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 83
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 83
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS 83
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY DEVICES 84
5.16.2 BUYING CRITERIA 84
FIGURE 24 KEY BUYING CRITERIA FOR RADIOTHERAPY 84
TABLE 20 KEY BUYING CRITERIA FOR RADIOTHERAPY 84
6 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE 85
6.1 INTRODUCTION 86
TABLE 21 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2022–2028 (USD MILLION) 86
6.2 PRODUCTS 86
6.2.1 CONTINUOUS DEVELOPMENT OF ADVANCED TECHNOLOGIES TO BOOST MARKET 86
TABLE 22 RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2022–2028 (USD MILLION) 87
 
6.3 SOFTWARE & SERVICES 87
6.3.1 INCREASING DEMAND FOR PRECISE AND EFFECTIVE CANCER TREATMENT TO SUPPORT MARKET GROWTH 87
TABLE 23 RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2022–2028 (USD MILLION) 88
7 RADIOTHERAPY MARKET, BY TECHNOLOGY 89
7.1 INTRODUCTION 90
TABLE 24 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 90
7.2 EXTERNAL BEAM RADIOTHERAPY 90
TABLE 25 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 90
TABLE 26 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 91
7.3 LINACS 91
TABLE 27 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 91
TABLE 28 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
7.3.1 CONVENTIONAL LINACS 92
7.3.1.1 Long treatment duration to limit adoption 92
TABLE 29 CONVENTIONAL LINACS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
7.3.2 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS 93
TABLE 30 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 31 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
7.3.2.1 CyberKnife 94
7.3.2.1.1 Precise radiation delivery with robotic correction capabilities to drive market 94
TABLE 32 CYBERKNIFE MARKET, BY REGION, 2021–2028 (USD MILLION) 94
7.3.2.2 Gamma Knife 95
7.3.2.2.1 Ongoing product development and launches to support growth 95
TABLE 33 GAMMA KNIFE MARKET, BY REGION, 2021–2028 (USD MILLION) 95
7.3.2.3 TomoTherapy 96
7.3.2.3.1 High installation and maintenance costs to limit adoption 96
TABLE 34 TOMOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 96
7.3.3 MRI LINACS 96
7.3.3.1 Real-time imaging advantage to propel growth 96
TABLE 35 MRI LINACS MARKET, BY REGION, 2022–2028 (USD MILLION) 97
7.4 PARTICLE THERAPY 97
TABLE 36 PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2021–2028 (USD MILLION) 97
TABLE 37 PARTICLE THERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 98
7.4.1 CYCLOTRONS 98
7.4.1.1 Enhanced outcomes and other advantages to boost adoption 98
TABLE 38 CYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION) 99
7.4.2 SYNCHROTRONS 99
7.4.2.1 Increasing investments in synchrotron facilities to drive market 99
TABLE 39 SYNCHROTRONS MARKET, BY REGION, 2021–2028 (USD MILLION) 100
7.4.3 SYNCHROCYCLOTRONS 100
7.4.3.1 High space requirements limit widespread adoption 100
TABLE 40 SYNCHROCYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION) 100
7.5 CONVENTIONAL COBALT-60 TELETHERAPY 101
7.5.1 COMPLEX DOSE DELIVERY PLANNING AND RADIATION EXPOSURE TO LIMIT MARKET ADOPTION 101
TABLE 41 CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 101
7.6 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY 102
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 102
7.7 SEEDS 103
7.7.1 ADVERSE SIDE-EFFECTS ASSOCIATED WITH SEEDS TO LIMIT ADOPTION 103
TABLE 44 SEEDS MARKET, BY REGION, 2021–2028 (USD MILLION) 103
7.8 AFTERLOADERS 103
7.8.1 PROPER POSITIONING AND BETTER CONTROL OF ISOTOPES IN MODERN AFTERLOADERS TO DRIVE DEMAND 103
TABLE 45 AFTERLOADERS MARKET, BY REGION, 2021–2028 (USD MILLION) 104
7.9 IORT SYSTEMS 104
7.9.1 RISING ADOPTION OF ELECTRONIC BRACHYTHERAPY PROCEDURES TO SUPPORT GROWTH 104
TABLE 46 IORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
7.10 APPLICATORS 105
7.10.1 HIGH RISK OF RADIATION EXPOSURE IN MANUAL APPLICATORS TO LIMIT GROWTH 105
TABLE 47 APPLICATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 106
7.11 SYSTEMIC RADIOTHERAPY 106
7.11.1 HIGH RISK OF RADIATION EXPOSURE TO LIMIT ADOPTION 106
7.11.2 IOBENGUANE (I-131) 106
7.11.3 SAMARIUM-153 107
7.11.4 RHENIUM-186 107
7.11.5 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS 107
8 RADIOTHERAPY MARKET, BY APPLICATION 108
8.1 INTRODUCTION 109
TABLE 48 RADIOTHERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109
8.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS 109
TABLE 49 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 109
TABLE 50 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION) 110
8.2.1 PROSTATE CANCER 110
8.2.1.1 High incidence rate and efficiency of EBRT in prostate cancer treatment to support growth 110
TABLE 51 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION) 111
8.2.2 BREAST CANCER 111
8.2.2.1 Therapeutic benefits of EBRT to drive market 111
TABLE 52 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION) 112
8.2.3 LUNG CANCER 112
8.2.3.1 High prevalence of lung cancer and efficiency of EBRT to drive market 112
TABLE 53 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION) 113
8.2.4 HEAD & NECK CANCER 113
8.2.4.1 Noninvasive treatment of head & neck cancers to drive market 113
TABLE 54 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2021–2028 (USD MILLION) 113
8.2.5 COLORECTAL CANCER 114
8.2.5.1 High incidence of colorectal cancer to support market growth 114
TABLE 55 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2021–2028 (USD MILLION) 114
8.2.6 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS 114
TABLE 56 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION) 115
8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS 115
TABLE 57 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 115
TABLE 58 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 116
8.3.1 PROSTATE CANCER 116
8.3.1.1 Precision of brachytherapy to drive market 116
TABLE 59 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2022–2028 (USD MILLION) 117
8.3.2 GYNECOLOGICAL CANCER 117
8.3.2.1 Availability of alternatives to hinder adoption of brachytherapy 117
TABLE 60 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2021–2028 (USD MILLION) 118
8.3.3 BREAST CANCER 118
8.3.3.1 Wide usage as replacement for traditional EBRT to drive market 118
TABLE 61 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION) 119
8.3.4 CERVICAL CANCER 119
8.3.4.1 Effectiveness of combined brachytherapy-chemotherapy procedure to support adoption 119
TABLE 62 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2021–2028 (USD MILLION) 120
8.3.5 PENILE CANCER 120
8.3.5.1 Rising awareness and effectiveness of brachytherapy to drive market 120
TABLE 63 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2021–2028 (USD MILLION) 121
8.3.6 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS 121
TABLE 64 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
9 RADIOTHERAPY MARKET, BY PROCEDURE 123
9.1 INTRODUCTION 124
TABLE 65 RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2028 (USD MILLION) 124
9.2 EXTERNAL BEAM RADIOTHERAPY 124
TABLE 66 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 67 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION) 125
9.2.1 IMRT 125
9.2.1.1 Advantages over 2D and 3D-CRT to boost adoption 125
TABLE 68 IMRT MARKET, BY REGION, 2021–2028 (USD MILLION) 126
9.2.2 IGRT 126
9.2.2.1 Growing demand in treating deep-seated tumors to drive market 126
TABLE 69 IGRT MARKET, BY REGION, 2021–2028 (USD MILLION) 127
9.2.3 3D CONFORMAL RADIOTHERAPY 127
9.2.3.1 High precision and minimized damage to nearby tissues to boost adoption 127
TABLE 70 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 128
9.2.4 SRT 128
9.2.4.1 Minimally invasive procedure to drive end-user preference 128
TABLE 71 SRT MARKET, BY REGION, 2021–2028 (USD MILLION) 129
9.2.5 PARTICLE THERAPY 129
9.2.5.1 High usage as primary mode of cancer treatment to sustain market growth 129
TABLE 72 PARTICLE THERAPY MARKET, BY REGION, 2022–2028 (USD MILLION) 130
9.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY 130
TABLE 73 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 74 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION) 131
9.3.1 LDR BRACHYTHERAPY 131
9.3.1.1 Low risk of radiation exposure to surrounding tissues to drive adoption 131
TABLE 75 LDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 132
9.3.2 HDR BRACHYTHERAPY 132
9.3.2.1 Possibility of tissue injury to affect adoption 132
TABLE 76 HDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 132
9.3.3 PDR BRACHYTHERAPY 133
9.3.3.1 Combination of advantages to boost growth 133
TABLE 77 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 133
9.4 SYSTEMIC RADIOTHERAPY 133
9.4.1 HIGH COST OF RADIOPHARMACEUTICALS AND RISK OF RADIATION EXPOSURE TO LIMIT USAGE 133
9.4.2 INTRAVENOUS RADIOTHERAPY 134
9.4.3 ORAL RADIOTHERAPY 134
9.4.4 INSTILLATION RADIOTHERAPY 134
10 RADIOTHERAPY MARKET, BY END USER 135
10.1 INTRODUCTION 136
TABLE 78 RADIOTHERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 136
10.2 HOSPITALS 136
10.2.1 HOSPITALS TO DOMINATE END-USER MARKET 136
TABLE 79 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 137
10.3 INDEPENDENT RADIOTHERAPY CENTERS 137
10.3.1 LOWER OPERATING COSTS AND CONVENIENCE TO SUPPORT MARKET GROWTH 137
TABLE 80 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021–2028 (USD MILLION) 137
11 RADIOTHERAPY MARKET, BY REGION 138
11.1 INTRODUCTION 139
TABLE 81 RADIOTHERAPY MARKET, BY REGION, 2022–2028 (USD MILLION) 139
11.2 NORTH AMERICA 139
11.2.1 NORTH AMERICA: RECESSION IMPACT 139
FIGURE 25 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT 140
TABLE 82 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 141
TABLE 83 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 141
TABLE 84 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 141
TABLE 85 NORTH AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 142
TABLE 86 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 142
TABLE 87 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 142
TABLE 88 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 143
TABLE 89 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 143
TABLE 90 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 144
TABLE 91 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 144
11.2.2 US 144
11.2.2.1 Changes in reimbursement scenario to drive market growth 144
TABLE 92 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 145
TABLE 93 US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 146
TABLE 94 US: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 146
TABLE 95 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 146
11.2.3 CANADA 147
11.2.3.1 Growing prevalence of cancer to drive demand for radiotherapy 147
TABLE 96 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 147
TABLE 97 CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 148
TABLE 98 CANADA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 148
TABLE 99 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 148
11.3 EUROPE 149
11.3.1 EUROPE: RECESSION IMPACT 149
TABLE 100 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 150
TABLE 101 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 150
TABLE 102 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 150
TABLE 103 EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 151
TABLE 104 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 151
TABLE 105 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 151
TABLE 106 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 152
TABLE 107 EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 152
TABLE 108 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 153
TABLE 109 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 153
11.3.2 GERMANY 153
11.3.2.1 Availability of novel radiotherapy products to drive market 153
TABLE 110 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 154
TABLE 111 GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 155
TABLE 112 GERMANY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 155
TABLE 113 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 155
11.3.3 FRANCE 156
11.3.3.1 High purchasing & maintenance costs of advanced radiotherapy systems to limit market growth 156
TABLE 114 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 156
TABLE 115 FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 156
TABLE 116 FRANCE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 157
TABLE 117 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 157
11.3.4 UK 157
11.3.4.1 High healthcare expenditure to drive market 157
TABLE 118 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 158
TABLE 119 UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 158
TABLE 120 UK: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 159
TABLE 121 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 159
11.3.5 SPAIN 159
11.3.5.1 Growing research activities on cancer care drive market 159
TABLE 122 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 160
TABLE 123 SPAIN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 161
TABLE 124 SPAIN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 161
TABLE 125 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 161
11.3.6 ITALY 162
11.3.6.1 High number of oncology-specific clinical trials & studies to support market growth 162
TABLE 126 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 162
TABLE 127 ITALY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 163
TABLE 128 ITALY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 163
TABLE 129 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 163
11.3.7 REST OF EUROPE 164
TABLE 130 REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 164
TABLE 131 REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 164
TABLE 132 REST OF EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 165
TABLE 133 REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 165
11.4 ASIA PACIFIC 165
11.4.1 ASIA PACIFIC: RECESSION IMPACT 166
FIGURE 26 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT 167
TABLE 134 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 168
TABLE 135 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 168
TABLE 136 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 169
TABLE 137 ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 169
TABLE 138 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 170
TABLE 139 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 170
TABLE 140 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 171
TABLE 141 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 171
TABLE 142 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 172
TABLE 143 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 172
11.4.2 JAPAN 172
11.4.2.1 Rising geriatric population and cancer incidence to drive market 172
TABLE 144 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 173
TABLE 145 JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 173
TABLE 146 JAPAN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 174
TABLE 147 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 174
11.4.3 CHINA 174
11.4.3.1 Growing partnerships among market players to support growth 174
TABLE 148 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 175
TABLE 149 CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 175
TABLE 150 CHINA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 176
TABLE 151 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 176
11.4.4 INDIA 176
11.4.4.1 High need for radiotherapy systems to provide opportunities 176
TABLE 152 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 177
TABLE 153 INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 177
TABLE 154 INDIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 178
TABLE 155 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 178
11.4.5 SOUTH KOREA 178
11.4.5.1 Increasing incidence of cancer to support market 178
TABLE 156 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 179
TABLE 157 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 179
TABLE 158 SOUTH KOREA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 180
TABLE 159 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 180
11.4.6 AUSTRALIA 180
11.4.6.1 Availability of funding for cancer care & research to drive growth 180
TABLE 160 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 181
TABLE 161 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 181
TABLE 162 AUSTRALIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 182
TABLE 163 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 182
11.4.7 REST OF ASIA PACIFIC 182
TABLE 164 REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 183
TABLE 165 REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 183
TABLE 166 REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 184
TABLE 167 REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 184
11.5 LATIN AMERICA 184
11.5.1 LATIN AMERICA: RECESSION IMPACT 185
TABLE 168 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION) 185
TABLE 169 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 185
TABLE 170 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 186
TABLE 171 LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 186
TABLE 172 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 186
TABLE 173 LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 187
TABLE 174 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2023–2028 (USD MILLION) 187
TABLE 175 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 188
TABLE 176 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 188
TABLE 177 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 189
11.5.2 BRAZIL 189
11.5.2.1 Restricted affordability & access to radiotherapy to challenge market growth 189
TABLE 178 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 189
TABLE 179 BRAZIL: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 190
TABLE 180 BRAZIL: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 190
TABLE 181 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 190
11.5.3 MEXICO 191
11.5.3.1 Rising target population to boost market growth 191
TABLE 182 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 191
TABLE 183 MEXICO: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 192
TABLE 184 MEXICO: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 192
TABLE 185 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 192
11.5.4 REST OF LATIN AMERICA 193
TABLE 186 REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 193
TABLE 187 REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 193
TABLE 188 REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 194
TABLE 189 REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 194
11.6 MIDDLE EAST & AFRICA 194
11.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET 194
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 195
TABLE 190 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION) 195
TABLE 191 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION) 196
TABLE 192 MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 196
TABLE 193 MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION) 196
TABLE 194 MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION) 197
TABLE 195 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION) 197
TABLE 196 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 198
TABLE 197 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION) 198
TABLE 198 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION) 199
12 COMPETITIVE LANDSCAPE 200
12.1 OVERVIEW 200
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 200
FIGURE 27 OVERVIEW OF STRATEGIES ADOPTED BY KEY RADIOTHERAPY PLAYERS (2020 TO 2023) 201
12.3 REVENUE ANALYSIS 202
FIGURE 28 REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019–2022 202
12.4 MARKET SHARE ANALYSIS 202
FIGURE 29 RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022 202
12.5 COMPANY EVALUATION MATRIX 203
12.5.1 STARS 203
12.5.2 EMERGING LEADERS 203
12.5.3 PERVASIVE PLAYERS 203
12.5.4 PARTICIPANTS 203
FIGURE 30 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022 204
12.5.5 COMPANY FOOTPRINT 205
TABLE 199 PRODUCT FOOTPRINT (18 COMPANIES) 205
TABLE 200 REGIONAL FOOTPRINT (18 COMPANIES) 206
TABLE 201 COMPANY FOOTPRINT (18 COMPANIES) 207
12.6 START-UP/SME EVALUATION MATRIX 207
12.6.1 PROGRESSIVE COMPANIES 207
12.6.2 RESPONSIVE COMPANIES 208
12.6.3 DYNAMIC COMPANIES 208
12.6.4 STARTING BLOCKS 208
FIGURE 31 RADIOTHERAPY MARKET: START-UP/SME EVALUATION MATRIX, 2022 208
12.6.5 COMPETITIVE BENCHMARKING 209
TABLE 202 RADIOTHERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES 209
12.7 COMPETITIVE SCENARIO AND TRENDS 210
12.7.1 PRODUCT LAUNCHES & APPROVALS 210
12.7.2 DEALS 210
12.7.3 OTHER DEVELOPMENTS 211

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（一般医療機器）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（hospital）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05　10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.